| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e493dbb326bdb84242fbc9af833f128e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D337-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D337-12 |
| filingDate |
1983-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_871b6d2740b885de9b1da925d24eceab |
| publicationDate |
1984-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0101234-A1 |
| titleOfInvention |
Therapeutic agent |
| abstract |
11-(3-dimethylaminopropylidene)-6,11-dihydro- dibenzo(b,e)thiepin-2-carbonitrile of formula In and pharmaceutically acceptable salts thereof show inhibition of neurotransmitter amine uptake and therefore have utility in the treatment of depression. |
| priorityDate |
1982-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |